|

TC011 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • TICAROS Co., Ltd.1

Indications

  • High-grade B-cell Lymphoma (HGBL)1
  • Refractory Large B-cell Lymphoma1
  • Relapsed Large B-cell Lymphoma1
  • Transformed Follicular Lymphoma (tFL)1
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)1

Other1 trial

Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.